ROTTERDAM, The Netherlands, January 11, 2021 – The partnership between the young company Pan Cancer T B.V. and Erasmus MC is awarded a Health~Holland grant of […]
– Strengthening of T cell research expertise to develop next-generation T cell therapies for patients with limited or no treatment options ROTTERDAM, January 17, 2023 – […]
– John Tchelingerian, PhD (Chair), Dharminder Singh Chahal and Prof. Dr. Chris Bangma to form Supervisory Board ROTTERDAM, March 30, 2021 – Pan Cancer T B.V., […]
Expanded investor syndicate strengthens the company’s financial position and investor base ROTTERDAM, October 28, 2021 – Pan Cancer T B.V., a biotech spin-off from the […]
TCR T cells towards solid tumors: perspective on pitfalls and opportunities Reno Debets, founder and CSO, PCT BV, Rotterdam, the Netherlands Rationale Adoptive T cell […]